|
| 36824269 | PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6. | iScience | 2023 |
| 37616468 | Inhibition of NAD+-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models. | Clin Cancer Res | 2023 |
| 36824269 | PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6. | iScience | 2023 |
| 37314923 | Using the single-cell imaging system and orthotropic footpad injection to establish mouse models for experimental and spontaneous melanoma metastasis. | STAR Protoc | 2023 |
| 37616468 | Inhibition of NAD+-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models. | Clin Cancer Res | 2023 |
| 37314923 | Using the single-cell imaging system and orthotropic footpad injection to establish mouse models for experimental and spontaneous melanoma metastasis. | STAR Protoc | 2023 |
| 33158997 | Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma. | Mol Cancer Ther | 2021 |
| 33158997 | Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma. | Mol Cancer Ther | 2021 |
| 32371575 | EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth. | Mol Cancer Ther | 2020 |
| 32371575 | EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth. | Mol Cancer Ther | 2020 |
| 32060262 | CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG. | Nat Commun | 2020 |
| 32908120 | Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma. | Oncogenesis | 2020 |
| 32060262 | CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG. | Nat Commun | 2020 |
| 32908120 | Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma. | Oncogenesis | 2020 |
| 30808861 | Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth. | Oncogenesis | 2019 |
| 30808861 | Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth. | Oncogenesis | 2019 |
| 31431459 | Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma. | Cancer Res | 2019 |
| 31416840 | Targeting the Chromosomal Passenger Complex Subunit INCENP Induces Polyploidization, Apoptosis, and Senescence in Neuroblastoma. | Cancer Res | 2019 |
| 31416840 | Targeting the Chromosomal Passenger Complex Subunit INCENP Induces Polyploidization, Apoptosis, and Senescence in Neuroblastoma. | Cancer Res | 2019 |
| 31431459 | Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma. | Cancer Res | 2019 |
| 29334376 | Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. | Nat Med | 2018 |
| 29973406 | MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma. | Sci Transl Med | 2018 |
| 29334376 | Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. | Nat Med | 2018 |
| 29634688 | Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. | Nat Med | 2018 |
| 29973406 | MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma. | Sci Transl Med | 2018 |
| 29634688 | Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. | Nat Med | 2018 |
| 28899971 | Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma. | Clin Cancer Res | 2017 |
| 28899971 | Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma. | Clin Cancer Res | 2017 |
| 28404949 | Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis. | Oncotarget | 2017 |
| 28404949 | Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis. | Oncotarget | 2017 |
| 27342399 | mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo. | Clin Cancer Res | 2016 |
| 27342399 | mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo. | Clin Cancer Res | 2016 |
| 27608846 | STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma. | Oncotarget | 2016 |
| 27835791 | The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma. | Transl Oncol | 2016 |
| 27973325 | Upregulation of Glucose-Regulated Protein 78 in Metastatic Cancer Cells Is Necessary for Lung Metastasis Progression. | Neoplasia | 2016 |
| 27608846 | STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma. | Oncotarget | 2016 |
| 27973325 | Upregulation of Glucose-Regulated Protein 78 in Metastatic Cancer Cells Is Necessary for Lung Metastasis Progression. | Neoplasia | 2016 |
| 27835791 | The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma. | Transl Oncol | 2016 |
| 25925378 | IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma. | Neoplasia | 2015 |
| 25925378 | IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma. | Neoplasia | 2015 |
| 26320182 | Characterization of the metastatic phenotype of a panel of established osteosarcoma cells. | Oncotarget | 2015 |
| 26497213 | Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma. | Oncotarget | 2015 |
| 26320182 | Characterization of the metastatic phenotype of a panel of established osteosarcoma cells. | Oncotarget | 2015 |
| 26497213 | Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma. | Oncotarget | 2015 |
| 24186204 | Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells. | Oncogene | 2014 |
| 24316974 | Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells. | J Clin Invest | 2014 |
| 24186204 | Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells. | Oncogene | 2014 |
| 24277455 | Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth. | Clin Cancer Res | 2014 |
| 24316974 | Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells. | J Clin Invest | 2014 |
| 24277455 | Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth. | Clin Cancer Res | 2014 |